Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
GPCR
Stock Latest News
The Fly
Structure Therapeutics initiated with Early-Stage Biotech at Goldman Sachs
4d ago
GPCR
Premium
Company Announcements
Structure Therapeutics Holds 2025 Annual Shareholders Meeting
18d ago
8K
GPCR
Premium
Ratings
Structure Therapeutics, Inc.: Catalyst-Rich Outlook and Strategic Preparations Support Buy Rating
1M ago
GPCR
Premium
The Fly
Structure Therapeutics price target raised to $80 from $75 at H.C. Wainwright
2M ago
GPCR
Premium
Ratings
Structure Therapeutics, Inc.: Promising Pipeline and Strong Financial Position Drive Buy Rating
2M ago
GPCR
Premium
Ratings
Buy Rating for Structure Therapeutics: Promising Phase 2b Results and Strategic Market Positioning
2M ago
GPCR
Premium
Ratings
Promising Developments in Weight Management Propel Buy Rating for Structure Therapeutics
2M ago
GPCR
Premium
Company Announcements
Structure Therapeutics Reports Increased Losses Amid Rising R&D Costs
2M ago
GPCR
Premium
The Fly
Apple downgraded, Reddit upgraded: Wall Street’s top analyst calls
2M ago
AZO
BDX
Premium
Ratings
Buy Recommendation for Structure Therapeutics: Promising Pipeline and Obesity Treatment Market Potential
2M ago
GPCR
Premium
The Fly
Structure Therapeutics initiated with a Buy at Citi
2M ago
GPCR
Premium
Ratings
Buy Rating for Structure Therapeutics: Aleniglipron’s Competitive Edge in the Oral GLP-1 Market
3M ago
GPCR
Premium
The Fly
Eli Lilly jumps as results from weight-loss pill study rival competitor’s
3M ago
LLY
NVO
Premium
The Fly
JPMorgan says Lilly data ‘highly favorable’ for Structure Therapeutics
3M ago
LLY
GPCR
Premium
The Fly
Smaller obesity drugmakers jump after Pfizer scraps weight-loss pill
3M ago
LLY
NVO
Premium
The Fly
JPMorgan says Pfizer news ‘mostly a positive’ for Structure, Viking
3M ago
PFE
GPCR
Premium
The Fly
Viking, Structure rally after Pfizer halts obesity drug development
3M ago
PFE
GPCR
Premium
Market News
Pfizer Stock (PFE) Dips after Weight-Loss Pill Halted Over Liver Injury
3M ago
AZN
LLY
Premium
Ratings
Structure Therapeutics, Inc.: Strong Pipeline and Financial Stability Underpin Buy Rating Despite Price Target Reduction
4M ago
GPCR
Premium
Company Announcements
Structure Therapeutics Advances in Obesity Treatment Pipeline
5M ago
GPCR
Premium
Ratings
Structure Therapeutics, Inc.: Promising Outlook with Aleniglipron in Obesity Treatment and Strategic Advancements Justify Buy Rating
5M ago
GPCR
Premium
The Fly
Structure Therapeutics price target lowered to $87 from $91 at Citizens JMP
5M ago
LLY
GPCR
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
